Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT2A receptor agonists [18 F]Cimbi-92 and [18 F]Cimbi-150

Research output: Contribution to journalJournal articleResearchpeer-review

Fraser Graeme Edgar, Hanne D Hansen, Sebastian Leth-Petersen, Anders Ettrup, Jesper L Kristensen, Gitte M Knudsen, Matthias M Herth

An agonist PET tracer is of key interest for the imaging of the 5-HT2A receptor, as exemplified by the previously reported success of [11 C]Cimbi-36. Fluorine-18 holds several advantages over carbon-11, making it the radionuclide of choice for clinical purposes. In this respect, an 18 F-labelled agonist 5-HT2A receptor (5-HT2A R) tracer is highly sought after. Herein, we report a 2-step, 1-pot labelling methodology of 2 tracer candidates. Both ligands display high in vitro affinities for the 5-HT2A R. The compounds were synthesised from easily accessible labelling precursors, and radiolabelled in acceptable radiochemical yields, sufficient for in vivo studies in domestic pigs. PET images partially conformed to the expected brain distribution of the 5-HT2A R; a notable exception however being significant uptake in the striatum and thalamus. Additionally, a within-scan displacement challenge with a 5-HT2A R antagonist was unsuccessful, indicating that the tracers cannot be considered optimal for neuroimaging of the 5-HT2A R.

Original languageEnglish
JournalJournal of Labelled Compounds and Radiopharmaceuticals
Volume60
Issue number12
Pages (from-to)586-591
Number of pages6
ISSN0362-4803
DOIs
Publication statusPublished - Oct 2017

    Research areas

  • Journal Article

ID: 187076476